Article Courtesy of Optel Group

In today’s global serialization landscape, pharmaceutical organizations must be able to connect with many networks and trading partners that use disparate inbound and outbound data transmission formats and protocols. To say this can make partner integrations challenging is an understatement.

In the pharma industry, time is money. Delayed deployments and postponed launches of a serialized product can result in the loss of thousands—even millions—of dollars.

To accommodate the huge variety of integration options, OPTEL’s flexible Verify Platform allows brand owners and CMOs/CPOs to rapidly connect to any pharmaceutical trading partner on any network while decreasing implementation times and offering value-added business benefits beyond regulatory compliance.